Non-melanoma skin cancer: Incidence time trends analysis in Girona, Spain, 1994-2007;Cáncer cutáneo distinto de melanoma: Tendencia de la incidencia poblacional en Girona, 1994-2007

Medicina Clinica

Volumn 137, Issue 4, 2011, Pages 145-151

  Vilar Coromina, Neus ^a,b   Miró Queralt, Josefina ^c   Cano Bautista, Annabel ^d   Vilardell Gil, Loreto ^d   Torres Babié, Priscila ^e   Marcos Gragera, Rafael ^d,f  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Hospital Sant Jaume de Calella   (Spain)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d Subdireccio General de Vigilancia I Resposta a Emergencies de Salut Publica   (Spain)

^e INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^f UNIVERSITY OF GIRONA   (Spain)

Author keywords

Basal cell carcinoma; Cutaneous squamous cell carcinoma; Incidence population; Non melanoma skin cancer

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; SKIN CANCER; SPAIN; SQUAMOUS CELL CARCINOMA;

AGE DISTRIBUTION; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORBIDITY; REGISTRIES; SEX DISTRIBUTION; SKIN NEOPLASMS; SPAIN;

EID: 79958859724     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.03.023     Document Type: Article

References (25)

1. Vilar Coromina N, Marcos-Gragera R. Linfomas primarios cutáneos: incidencia y supervivencia poblacional, 1994-2004. Med Clin (Barc). 2008;131:396-7.
2. Vilar-Coromina N, Perez Bueno F, Alsina M, Vilardell L, Izquierdo A, Marcos-Gragera R. Carcinoma de células de Merkel cutáneo: incidencia y supervivencia poblacional, 1995-2005. Med Clin (Barc). 2009;132:701-3.
3. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375:673-85.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
5. Marcos-Gragera R, Cardo X, Galceran J, Ribes J, Izquierdo A, Borras J. Incidencia del cáncer en Cataluña, 1998-2002. Med Clin (Barc). 2008;131 Suppl 1:4-10.
6. Institut d'Estadística de Catalunya; 2010 [consultado 24/09/10]. Disponible en: http://www.idescat.es.
7. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan S. Comparability and Quality Control in Cancer Registration. Lyon: IARC; 1994.
8. a ed. Barcelona: Thau; 2000.
9. Frit A, Jack A, Percy C, Shanmugaratnam K, Sobin L, Parkin M, et al. International Classification of Diseases for Oncology, 3rd ed., Geneva: World Health Organisation ed; 2000.
10. Tyczynski J, Démaret E, Parkin M. Standards and guidelines for cancer registration in Europe. IARC Technical Publication N8 40. Lyon: IARC; 2003.
11. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai: Tohoku University School of Public Health; 1960.
12. Statistical Research and Applications Branch National Cancer Institute; 2010 [consultado 4/05/2010]. Disponible en: http://srab.cancer.gov/joinpoint.
13. Birch-Johansen F, Jensen A, Mortensen L, Olesen AB, Kjaer SK. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women. Int J Cancer. 2010;127:2190-2198.
14. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149:1200-6. (Pubitemid 38058096)
15. Brewster DH, Bhatti LA, Inglis JH, Nairn ER, Doherty VR. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol. 2007;156:1295-300.
16. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol. 2000;143:1224-9.
17. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6-10.
18. Bielsa I, Soria X, Esteve M, Ferrandiz C. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. Br J Dermatol. 2009;161:1341-6.
19. Hoey SE, Devereux CE, Murray L, Catney D, Gavin A, Kumar S, et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol. 2007;156:1301-7. (Pubitemid 47029856)
20. De Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol. 2005;152:481-8. (Pubitemid 40547122)
21. Kricker A, Armstrong BK, English DR, Heenan PJ. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer. 1995;60:489-94.
22. Marcos-Gragera R, Vilar-Coromina N, Galceran J, Borras J, Cleries R, Ribes J, et al. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol. 2010;24:1083-8.
23. Vilar-Coromina N, Vilardell L, Cano A, Marcos-Gragera R. Rápido incremento de la incidencia delmelanoma insitu en Girona (España) 1994-2005. ¿Efectividad de la campañas de diagnóstico precoz? Actas Dermosifiliogr. 2010;101:561-3.
24. De Vries E, Louwman M, Bastiaens M, De Gruijl F, Coebergh JW. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol. 2004;123:634-8.
25. Hayes RC, Leonfellner S, Pilgrim W, Liu J, Keeling DN. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J Cutan Med Surg. 2007;11:45-52.